Europe Age-related Macular Degeneration Market Highlights - Analysis & Opportunities 2015-2020

Dec 21, 2015, 09:10 ET from Research and Markets

DUBLIN, Dec. 21, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/ckxgqz/europe) has announced the addition of the "Europe Age-related Macular Degeneration Market Highlights - 2015" report to their offering.

The report, 'Europe Age-related Macular Degeneration Market Highlights - 2015', provides analysis for the Europe Age-related macular degeneration market, competitive landscape, and Age-related macular degeneration drug sales forecast.

The research helps executives track competitor drugs sales and market share in Europe Age-related macular degeneration market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the Europe Age-related macular degeneration market.

Highlights of the Research:

  • Marketed Age-related Macular Degeneration Drugs in Europe
  • Europe Age-related Macular Degeneration Market Analysis
  • Age-related Macular Degeneration Drugs Sales Analysis in Europe
  • Competitive Landscape in Europe Age-related Macular Degeneration market
  • Age-related Macular Degeneration Late Stage Pipeline
  • Europe Age-related Macular Degeneration Market Forecast
  • Age-related Macular Degeneration Drugs Sales Forecast in Europe
  • Future Competitive Landscape 

Benefits of this Report:

  • Identify drugs marketed in Europe for treating Age-related macular degeneration including trade name, molecule name, and company.
  • Find out estimates for Europe Age-related macular degeneration market size in 2014, key products and their sales, and how the market and products advanced from 2011. You will benefit from our accurate country and indication level valuation of products and the market.
  • Know the market share of leading Age-related macular degeneration brands in Europe, including generics share.
  • Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of Age-related macular degeneration. Our coverage includes molecule, mechanism of action, and the company.
  • Gain insights into how Europe Age-related macular degeneration market will advance along with market forecast till 2020.

Report Structure:

1. Age-related Macular Degeneration - Disease Definition

2. Marketed Age-related Macular Degeneration Drugs in Europe

3. Europe Age-related Macular Degeneration Market Analysis

4. Competitive Landscape in Europe Age-related Macular Degeneration Market

5. Europe Age-related Macular Degeneration Market - Future Market Outlook

For more information visit http://www.researchandmarkets.com/research/ckxgqz/europe

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com
http://www.researchandmarkets.com